General Anesthesia Improves Efficiency of High-Power Short-Duration Catheter Ablation for Atrial Fibrillation: Comparison with Mild Conscious Sedation.

atrial fibrillation catheter ablation general anesthesia high-power short duration mild conscious sedation

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
16 Aug 2024
Historique:
received: 11 07 2024
revised: 28 07 2024
accepted: 13 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Atrial fibrillation (AF) is the most common cardiac arrhythmia globally. High-power, short-duration radiofrequency (RF) catheter ablation (CA) for AF has recently emerged, reducing ablation times and enhancing patient tolerability with comparable efficacy and safety. While the benefits of general anesthesia (GA) for standard-power, standard-duration CA are well-established, data comparing GA to mild conscious sedation (MCS) for high-power, short-duration CA are limited. We included patients undergoing high-power, short-duration CA for AF under GA (group 1) or MCS (group 2). Procedural characteristics, success rates, and mid-term outcomes were compared. In total, 131 patients, 47 in the GA group and 84 in the MCS group, were included. CA was performed for paroxysmal AF in 34 patients in group 1 (72.3%) and 68 patients in group 2 (80.9%). We found lower a mean total procedure time (100 [90-120] vs. 160 [130-180] min, In patients undergoing high-power, short-duration RFCA for AF, the use of GA is associated with better procedural efficiency while simultaneously associated with an early recurrence rate comparable to MCS.

Sections du résumé

BACKGROUND BACKGROUND
Atrial fibrillation (AF) is the most common cardiac arrhythmia globally. High-power, short-duration radiofrequency (RF) catheter ablation (CA) for AF has recently emerged, reducing ablation times and enhancing patient tolerability with comparable efficacy and safety. While the benefits of general anesthesia (GA) for standard-power, standard-duration CA are well-established, data comparing GA to mild conscious sedation (MCS) for high-power, short-duration CA are limited.
METHODS METHODS
We included patients undergoing high-power, short-duration CA for AF under GA (group 1) or MCS (group 2). Procedural characteristics, success rates, and mid-term outcomes were compared.
RESULTS RESULTS
In total, 131 patients, 47 in the GA group and 84 in the MCS group, were included. CA was performed for paroxysmal AF in 34 patients in group 1 (72.3%) and 68 patients in group 2 (80.9%). We found lower a mean total procedure time (100 [90-120] vs. 160 [130-180] min,
CONCLUSION CONCLUSIONS
In patients undergoing high-power, short-duration RFCA for AF, the use of GA is associated with better procedural efficiency while simultaneously associated with an early recurrence rate comparable to MCS.

Identifiants

pubmed: 39202056
pii: jpm14080865
doi: 10.3390/jpm14080865
pmc: PMC11355396
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Heart Rhythm. 2011 Mar;8(3):368-72
pubmed: 21055479
Circulation. 2024 Jan 2;149(1):e1-e156
pubmed: 38033089
Europace. 2018 Jun 1;20(6):935-942
pubmed: 28444228
Heart Asia. 2019 Aug 14;11(2):e011155
pubmed: 31565074
J Interv Card Electrophysiol. 2023 Mar;66(2):445-453
pubmed: 35997848
Heart Rhythm. 2019 Feb;16(2):165-169
pubmed: 30712645
Pacing Clin Electrophysiol. 2014 Jun;37(6):781-90
pubmed: 24697803
Heart Vessels. 2017 Aug;32(8):997-1005
pubmed: 28260190
J Cardiovasc Electrophysiol. 2022 Aug;33(8):1714-1722
pubmed: 35652836
Sci Rep. 2023 Oct 11;13(1):17204
pubmed: 37821563
Europace. 2021 Dec 7;23(12):2039-2045
pubmed: 34308973
Heart Rhythm. 2024 Sep;21(9):e31-e149
pubmed: 38597857
Pacing Clin Electrophysiol. 2016 Dec;39(12):1359-1365
pubmed: 27747896
Arrhythm Electrophysiol Rev. 2020 Feb 12;8(4):265-272
pubmed: 32685157
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
J Interv Card Electrophysiol. 2024 Mar;67(2):227-229
pubmed: 37897536
Europace. 2013 Jan;15(1):41-7
pubmed: 22915788
J Cardiovasc Electrophysiol. 2022 Aug;33(8):1723-1724
pubmed: 35652825

Auteurs

Ioan-Alexandru Minciună (IA)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Raluca Tomoaia (R)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Mihai Suceveanu (M)

Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Gabriel Cismaru (G)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Mihai Puiu (M)

Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Radu Roșu (R)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Gelu Simu (G)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Diana Andrada Irimie (DA)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Florina Frîngu (F)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Bogdan Caloian (B)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Marius Andronache (M)

Alleray-Labrouste Cardiology Clinics, 75015 Paris, France.

Dumitru Zdrenghea (D)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.

Dana Pop (D)

5th Department of Internal Medicine, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Cardiology Department, Rehabilitation Hospital, 400066 Cluj-Napoca, Romania.

Classifications MeSH